Incyte is strutting its stuff to boost awareness and support for people with vitiligo—with help from supermodel Winnie Harlow ...

Lawmakers are proposing a new effort to strengthen biopharma manufacturing in the U.S., leveraging a bill that seeks to ...

Back in August, the FDA announced that it was working on a new program dubbed FDA PreCheck, which broadly aims to improve ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...

The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM), which spurred excitement over a potential $20 billion ...

The U.S. House of Representatives has given a unanimous thumbs up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...

Following the deal’s Nov. 26 close, Omnicom on Monday outlined the structure of the newly combined company, including leaders ...

In this episode of Health Matters, GCI Health’s Ryan Kuresman and Health@WPP’s Wendy Lund explore the fast-shifting landscape ...

The Trump administration has lined up another country-specific trade agreement, this time with the U.K., which confers Washington’s biggest break on pharmaceutical import tariffs yet. | The Trump ...

Mitsubishi Tanabe Pharma has undergone a rebrand. Following a 510 billion Japanese yen ($3.3 billion) takeover by Bain Capital, the 350-year-old company has dropped Mitsubishi from its name and those ...